Antidepressants – The new endocrine disruptors? The case of crustaceans

Thomas Knigge
DOI: https://doi.org/10.1016/j.mce.2024.112155
IF: 4.369
2024-01-07
Molecular and Cellular Endocrinology
Abstract:Antidepressants are high-volume pharmaceuticals that accumulate to concentrations in the μg·L −1 range in surface waters. The release of peptide hormones via neurosecretory cells appears as a natural target for antidepressants. Here I review research that suggests that antidepressants indeed disrupt endocrine signalling in crustaceans, by acting on the synthesis and release of neurohormones, such as crustacean hyperglycaemic hormone, moult inhibiting hormone and pigment dispersing hormone in decapods, as well as methyl farnesoate in Daphnids. Hence, antidepressants can affect hormonal regulation of physiological functions: increase in energy metabolism and activity, lowered ecdysteroid levels, potentially disrupting moult and somatic growth, reducing colour change capacity and compromising camouflage, as well as induction of male sex determination. Several studies further suggest effects of antidepressants on crustacean reproduction, but the hormonal regulation of these effects remains elusive. All things considered, a body of evidence strongly suggests that antidepressants are endocrine disrupting compounds in crustaceans.
cell biology,endocrinology & metabolism
What problem does this paper attempt to address?